METHOD FOR DIAGNOSING MOLECULAR PHENOTYPE OF PATIENTS SUFFERING FROM DISEASES ACCOMPANIED BY CHRONIC INFLAMMATION Russian patent published in 2018 - IPC G01N33/68 C12Q1/68 A61K9/113 A61K48/00 A61P29/00 

Abstract RU 2672595 C2

FIELD: medicine.

SUBSTANCE: proposed group of inventions relates to medicine. Proposed are a method and a set for diagnosing the molecular phenotype of patients suffering from a disease accompanied by chronic inflammation, and classified as "Th2-high", "Th2-low", "Th1-high" or "Th1-low". Proposed is a medication for the treatment of such patients, containing a DNA-enzyme specific for GATA-3 or Tbet.

EFFECT: proposed group of inventions provides effective methods for determining the molecular phenotype of a patient suffering from a disease accompanied by chronic inflammation, and medications that are effective for the identified subgroup of patients.

9 cl, 9 dwg, 1 tbl, 7 ex

Similar patents RU2672595C2

Title Year Author Number
MODULATION OF EXPRESSION OF CYTOKINES TH1/TH2 BY RIBAVIRIN AND RIBAVIRIN ANALOGS IN ACTIVATED T-LYMPHOCYTES 1997
  • Tehm Robert
  • Rejmasejmi Kehndsejmi
  • Ehverett Devron
RU2186569C2
GATA-3 INHIBITORS FOR USE IN TREATING TH2-INDUCED ASTHMA 2016
  • Bille Joachim
  • Renz Jonas
RU2720988C2
METHOD FOR EVALUATING PYORRHOEA ON PARADONTIUM BASED ON LEVEL OF HUMAN INTERLEUKIN-8 (IL-8) GENE MRNA 2015
  • Zorina Oksana Aleksandrovna
  • Ajmadinova Nelli Kamilevna
  • Shibaeva Anna Valerevna
  • Rebrikov Denis Vladimirovich
  • Trubnikova Elena Vladimirovna
  • Shevelev Aleksej Borisovich
  • Kudykina Yuliya Konstantinovna
  • Boldinova Elizaveta Olegovna
  • Petrukhina Natalya Borisovna
  • Trofimov Dmitrij Yurevich
RU2607041C2
PROGNOSIS METHOD OF DEVELOPMENT OF ALLERGIC RHINITIS 2016
  • Martynov Aleksandr Igorevich
  • Andreev Igor Vladimirovich
  • Sankov Mikhail Nikolaevich
  • Donetskova Almira Dmitrievna
RU2611402C1
HUMAN IL-4 MUTEIN, POLYNUCLEOTIDE MOLECULE, VECTOR, STRAIN SF9 TRANSFORMED WITH VECTOR, METHOD FOR SELECTION OF MUTEIN, PHARMACEUTICAL COMPOSITION FOR ACTIVATION OF T CELLS, METHOD FOR TREATMENT OF PATIENT SUFFERING WITH DISEASE AND SUSCEPTIBLE FOR TREATMENT WITH IL-4 1997
  • Shehnehfelt Armen B.
  • Greve Dzhefri
  • Gandel Robert
RU2235728C2
APPLICATION OF MYCOBACTERIUM VACCAE FOR FEEDBACK INHIBITION REGULATION OF TH2-ACTIVITY OF IMMUNE SYSTEM 1997
  • Ruk Grehkhehm Artur Vill'Jam
  • Stehnford Dzhon Losan
  • Zumla Alimuddin Ismail
RU2197989C2
MOUSE MODEL OF INFLAMMATION WITH IL33 N-TERMINAL DOMAIN DELETION 2011
  • Kote-Serra Khaver
  • Iglesias Antonio
  • Mejer Klaas Ajko
RU2577988C2
STRAIN LACTOBACILLUS PARACASEI CNCM I-2116 (NCC 2461) ELICITING ABILITY TO PREVENT COLONIZATION OF INTESTINE WITH DIARRHEA-CAUSING PATHOGENIC MICROORGANISMS AND TO PREVENT INFECTION OF INTESTINE EPITHELIAL CELLS WITH ROTAVIRUSES, FOODSTUFF AND PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND/OR TREATMENT OF DIARRHEA-ASSOCIATED DISEASES 2000
  • Ren'Ero Roberto
  • Brjussou Garal'D
  • Rosha Florans
  • Fon Der Vajd T'Erri
  • Blum-Sperizen Stefani
  • Nezer Zhan-Rishar
  • Servehn Alen
RU2247569C2
METHOD FOR ASSESSMENT OF EFFICIENCY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN ALLERGIC RHINITIS 2019
  • Donetskova Almira Dmitrievna
  • Smirnov Dmitrij Sergeevich
  • Kurbacheva Oksana Mikhajlovna
  • Litvina Marina Mikhajlovna
  • Nikonova Margarita Fedorovna
  • Mitin Aleksandr Nikolaevich
RU2700788C1
MODULATION OF EXPRESSION OF STAT-1-DEPENDED GENES 2002
  • Kheker Markus
  • Vagner Andreas Kh.
RU2311456C2

RU 2 672 595 C2

Authors

Bille Joakhim

Turovska Agneshka

Dates

2018-11-16Published

2013-09-04Filed